HEALTHCARE
The Waiting Room Podcast
Season 2
About This Season
In season 2 of The Waiting Room we continue to speak with experts from the world of healthcare. Two episodes focus on the work of the UK enterprise Diversity and Ability (D&A), and a two-part special feature covers the rare disease Waldenström macroglobulinemia. Suicide prevention, health literacy and lung cancer are among the other topics of this season.
All Episodes
Episode 10 - Colorectal Cancer Awareness Month with Stephen Rowley (Part 2)
For this episode of Karger’s The Waiting Room Podcast on Colorectal Cancer Awareness Month in March, we spoke with Stephen Rowley. He is a colorectal cancer survivor, and currently serves as Patient Advisor at Digestive Cancers Europe.
In our interview we focus on the aspects of prevention and screening, stigmatization, and cancer rehabilitation regarding colorectal cancer.
This is the second part of our two-part special on colorectal cancer. The first part was published on March 9, 2023.
Supplementary Material
Episode 9 - Colorectal Cancer Awareness Month with Stephen Rowley (Part 1)
For this episode of Karger’s The Waiting Room Podcast on Colorectal Cancer Awareness Month in March, we spoke with Stephen Rowley. He is a colorectal cancer survivor, and currently serves as Patient Advisor at Digestive Cancers Europe.
In our interview we focus on the aspects of prevention and screening, stigmatization, and cancer rehabilitation regarding colorectal cancer.
This is the first part of our two-part special on colorectal cancer. The second part will be published on March 23, 2023.
Supplementary Material
Episode 8 - “Anyone with Lungs Can Get Lung Cancer”: An Interview with Dr Anne-Marie Baird
For this episode of Karger’s The Waiting Room Podcast, we spoke with Dr Anne-Marie Baird, who currently serves as the president of Lung Cancer Europe (LuCE). She is a Senior Research Fellow at Trinity College Dublin, Ireland, and a patient advocate.
LuCE is the voice of Europeans impacted by lung cancer. The aim of LuCE is to destigmatise the disease and ensure that those impacted by lung cancer get the care they need to achieve the best possible outcomes.
Supplementary Material
Episode 7 - Rare Disease Day 2023 with Lisa Sarfaty
For this episode of Karger’s The Waiting Room Podcast on Rare Disease Day 2023, which is held on February 28, we spoke with Lisa Sarfaty from the National Organization for Rare Disorders (NORD). Lisa currently serves as the Vice President of Community Engagement, and particularly focuses on advocacy, education, and capacity building.
While addressing the 40th anniversary of the Orphan Drug Act (ODA) and of the foundation of NORD as an organization, we specifically tried to answer the question: “What does equity mean for people living with a rare disease?” We also looked at what should be done to actually achieve this equity in education, the workplace, and everyday life. Last but not least, we had a closer look at NORD’s plans for Rare Disease Day 2023.
Episode 6 - Zero Suicide Alliance with Jade Corbridge
For this episode of Karger’s The Waiting Room Podcast, we spoke with Jade Corbridge from the Zero Suicide Alliance. It seems that the word “suicide” alone is a taboo and should not be mentioned. Naturally, this makes it difficult or even impossible to initiate a conversation with someone who might be feeling suicidal. How do you best approach them? How can you help them? However, Jade is familiar with these questions, and luckily agreed to be our guest.
For further information, you can also go to the 24/7 Helpline of the Samaritans or find a suitable helpline.
Episode 5 - Waldenström macroglobulinemia with Shirley D’Sa
Waldenström macroglobulinemia (WM) is a rare blood cancer that usually progresses slowly. WM can be diagnosed by blood tests, bone marrow biopsy, and scans, and there are a range of treatment options available.
In this episode of Karger’s The Waiting Room Podcast, we spoke with Dr Shirley D’Sa to learn more about WM. She is a Consultant Haematologist and Honorary Associate Professor at University College London Hospitals NHS Foundation Trust in London, UK. Furthermore, she is the author of the booklet Fast Facts for Patients: Waldenström macroglobulinemia, which is freely available online.
This is the second interview of our two-part special on Waldenström macroglobulinemia. Find the interview with Bob Perry, Patient Support Manager at Waldenström Macroglobulinaemia UK.
Supplementary Material
Episode 4 - Waldenström Macroglobulinemia with Bob Perry
Waldenström macroglobulinemia (WM) is a rare blood cancer that usually progresses slowly. WM can be diagnosed by blood tests, bone marrow biopsy, and scans, and there are a range of treatment options available.
In this episode of Karger’s The Waiting Room Podcast, we talk with Bob Perry. He was diagnosed with Waldenström macroglobulinemia (WM) in 2015 and treated with chemotherapy. Since then, he set up a support group, the Bournemouth and District WM Support Group aka the BAD WMers. He is also Patient Support Manager at the UK charity Waldenström Macroglobulinaemia UK (WMUK).
This is the first interview of our two-part special on Waldenström macroglobulinemia. The second part, focusing on symptoms, diagnosis and treatment of WM, features Dr Shirley D’Sa. She is a Consultant Haematologist and Honorary Associate Professor at University College London Hospitals NHS Foundation Trust in London, UK, as well as the author of the booklet Fast Facts for Patients: Waldenström Macroglobulinemia, which is freely available online.
Supplementary Material
Book: Fast Facts: Waldenström Macroglobulinemia
Blog post: Interview with Bob Perry
Episode 3 - Health Literacy with Catherine Richards Golini
In this episode of Karger’s The Waiting Room Podcast, we talk with Catherine Richards Golini, who works as a Healthcare Publications Editor at Karger Publishers, about health literacy. The World Health Organization (WHO) defines health literacy as “the cognitive and social skills which determine the motivation and ability of individuals to gain access to, understand and use information in ways which promote and maintain good health”.
While we can’t influence the level of knowledge or personal skills of an individual, we can make sure the information we as a publisher offer is relevant and easy to understand. Thus, we support patients and their supporters in their efforts to make informed decisions and be on a level playing field with all actors of the health care system.
Supplementary Material
Episode 2 - Diversity and Ability (D&A) with Brian Lutchmiah and Piers Wilkinson
In this episode of Karger’s The Waiting Room Podcast, we talk with Brian Lutchmiah and Piers Wilkinson about the work and achievements of their organization Diversity and Ability (D&A) and the upcoming inaugural congress in December.
D&A is a UK-based social enterprise led by and for disabled people, i.e., 85% of their team self-identify as disabled or neurodiverse. Their aim is to support individuals, organisations and social justice projects to create inclusive cultures.
This is the second interview of our two-part special featuring D&A. The first part focuses on UK Disability History Month, which runs from November 16 until December 16, 2022.
Supplementary Material
Episode 1 - UK Disability History Month 2022 with Piers Wilkinson
In this episode of Karger’s The Waiting Room Podcast, we talk with Piers Wilkinson from Diversity and Ability (D&A) about UK Disability History Month, which runs from November 16 to December 16, 2022, and features the theme “Disability, Health and Wellbeing”.
D&A is a UK-based social enterprise led by and for disabled people, i.e., 85% of their team self-identify as disabled or neurodiverse. Their aim is to support individuals, organisations and social justice projects to create inclusive cultures.
This is the first interview of a two-part special featuring D&A. The second part focuses on the work of the organization and its upcoming inaugural congress in December. It will feature Piers Wilkinson and Brian Lutchmiah.
Supplementary Material
About the Speakers
Piers Wilkinson
Piers Wilkinson is the former National Union of Students (NUS) Disabled Students’ Officer, and now supports the work of Diversity and Ability (D&A) as the Policy and Campaigns Lead of the Inclusive Education Team.
Brian Lutchmiah
Brian Lutchmiah currently works as an Education Consultant for Diversity and Ability (D&A) and acted as the Manager of its Inclusive Education Team until recently. Furthermore, he is the Chair of the English Policy Group of the Universities and Colleges Admissions Service (UCAS) as well as a Senior Accredited Member of the National Association of Disability Practitioners (NADP).
Catherine Richards Golini
Catherine Richards Golini is a Healthcare Publications Editor at Karger Publishers. Catherine is an experienced medical editor, a teacher of English for medical purposes and a writer of plain language summaries (PLS) and patient resources. She holds a PhD in Applied Linguistics from the University of Swansea in Wales.
Bob Perry
Bob Perry was diagnosed with Waldenström macroglobulinemia (WM) in 2015 and treated with chemotherapy. Since then, he set up a support group, the Bournemouth and District WM Support Group aka the BAD WMers. He is also Patient Support Manager at the UK charity Waldenström Macroglobulinaemia UK (WMUK).
Dr Shirley D’Sa
Dr Shirley D’Sa is a Consultant Haematologist and Honorary Associate Professor at University College London Hospitals NHS Foundation Trust in London, UK. Furthermore, she is the author of the booklet Fast Facts for Patients: Waldenström macroglobulinemia, which is freely available online.
Jade Corbridge
Jade Corbridge is a first class MSci Psychological Sciences graduate from the University of Liverpool. She has experience working in the Mental Health and Addiction sector, which is her primary area of interest. Currently she is a Research and Development Assistant for Zero Suicide Alliance, Mersey Care. For more information, go to the Zero Suicide Alliance website.
Lisa Sarfaty
Lisa Sarfaty joined the National Organization for Rare Disorders (NORD) in 2011 and currently serves as the Vice President of Community Engagement. She coordinates the organization’s community outreach and engagement programs and is working closely with global partners on advocacy, education, and capacity building.
Dr Anne-Marie Baird
Since 2020, Dr Anne-Marie Baird is the president of Lung Cancer Europe (LuCE). She is a Senior Research Fellow at Trinity College Dublin, Ireland, and a patient advocate. As a cancer molecular biologist, she researches inflammation and immune mediators, metastatic cascade, drug resistance and disease biomarkers. As a patient advocate, she is involved in many patient councils, steering committees and advisory boards.
Stephen Rowley
Stephen Rowley is a colorectal cancer survivor, and currently serves as Patient Advisor at Digestive Cancers Europe. Stephen also helps to organize cancer rehabilitation services and founded the national Bowel Cancer Support Group UK. Furthermore, apart from having played a role in the development of the internet and internet security, he is an interdisciplinary scientist, active musician, visual artist and keen sailor.